Valeant to buy private dental company for $312 million
Valeant to buy private dental company for $312 million (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc will buy privately held drugmaker OraPharma for about $312 million, to enter the dental market. The company, which has been on a buying spree across various geographies since Michael Pearson took over as its chief executive four years ago, said it will also pay $114 million in potential contingent payments based on certain milestones. The deal, which is expected to close in June, will add to Valeants earnings in 2012, the company said in a statement. ... //news.yahoo.com/valeant-buy-private-dental-company-312-million-122600295--finance.html
Create Date : 18 มิถุนายน 2555 |
Last Update : 18 มิถุนายน 2555 15:38:39 น. |
|
0 comments
|
Counter : 779 Pageviews. |
|
|
|
|
|